PHARMACY

Dr. Reddy’s intros generic Renvela

BY David Salazar

HYDERABAD, India, and PRINCETON, N.J. — Dr. Reddy’s Laboratories recently launched its generic of Renvela (sevelamer carbonate) tablets. The drug is indicated to control serum phosphorus in adults and children ages 6 years and older with chronic kidney disease who are on dialysis.

“We are very pleased to bring Sevelamer Carbonate Tablets to market at this time,” Dr. Reddy’s EVP and head of North American generics Alok Sonig said. “This launch represents Dr. Reddy’s expertise and commitment to provide affordable alternatives for complex, limited-competition products to market.” This is the Company’s eighth overall and fourth limited-competition launch this fiscal year.

The Dr. Reddy’s generic is available in 800-mg dosage strength in 270-count bottles. For the 12 months ended July 2017, the drug had U.S. sales of roughly $1.88 billion, according to QuintilesIMS data.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Amazon reportedly still mulling online drug sales

BY DSN STAFF

Amazon is deciding how to get a foothold into the multibillion-dollar prescription drug market.

The online giant is expected to make a decision before Thanksgiving of whether it will sell prescription drugs online. These details came from an email from Amazon, as well as a source familiar with the situation, according to CNBC.

If Amazon moves forward with this new offering, the company will begin expanding its senior team with drug supply chain experts. This is in addition to the dozens of people it has already hired and consulted with regarding its potential move into the pharmacy market. Among them is Amazon’s consumables team’s VP, Eric French, the report said.

According to an anonymous source, Amazon is still evaluating — and aware of — the complexities this segment presents, CNBC reported.

To read more, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Parata, AAP ink purchasing agreement

BY David Salazar

DURHAM, N.C. — Member-owned pharmacy cooperative American Associated Pharmacies has entered a group purchasing agreement with pharmacy technology company Parata Systems, the companies announced Monday.

“Parata's tireless devotion to helping pharmacies improve their businesses aligns well with AAP's goal to provide pharmacies with tools to enhance profitability, streamline operations, and improve the quality of patient care,” AAP VP preferred partners Tracie Heyrman said.
“Our partnership with Parata provides AAP members access to innovative automation solutions from an industry-leader known for their dedication to their customers' success.”

The agreement allows AAP’s more than 2,200 member independent pharmacies special pricing and pre-negotiated terms for pharmacy technology. Parata's offerings include such pharmacy automation choices as vial-filling and pouch packaging solutions, and its Parata PASS medication management suite is aimed at helping patients adhere to their medication regimens. 

"We admire AAP's focus on helping their members strengthen and grow their businesses through the best services and the latest technologies," said Scott Hollis, Parata's vice president of sales. "Parata couldn't be more thrilled to offer our expertise to contribute to this mission."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?